← Leaderboards
Eric Sorenson
Mayo Clinic Coll Of Medicine, Rochester
$8,291,522
Attributed
$8,291,522
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$8,291,522 · 2
By mechanism
R01$7,691,582 · 1
K23$599,940 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Phillip A Low$10,116,600
- Peter James Dyck$6,777,249
- Paola Sandroni$614,937
- Tanis Jill Ferman$2,601,779
- Rose Dotson$0
Others in their field
Top investigators on “Muscle Strength”
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$34,642,890
- Peter J. Snyder · University Of Pennsylvania$32,676,086
- Jay Steven Magaziner · University Of Maryland Baltimore$28,975,709
- Robert E Hillman · Massachusetts Eye And Ear Infirmary$20,027,130
- Krista H Vandenborne · University Of Pennsylvania$17,965,374
- Laura E. Nagy · Case Western Reserve University$16,385,490
Research focus
Muscle StrengthAmyotrophic Lateral SclerosisHuman SubjectClinical ResearchClinical TrialsDiagnosis Design /EvaluationQuestionnairesLongitudinal Human StudyNeural ConductionNervous System Disorder DiagnosisAgingNeuromuscular FunctionPoliomyelitisAge DifferenceNeurologic ManifestationsDrug Screening /EvaluationMuscle FunctionPatient Oriented ResearchNeurotransmitter AntagonistNeuroprotectantsNeuromuscular Disorder ChemotherapyInsulinlike Growth FactorHuman Therapy EvaluationThiazoles
Grant awards (13)
IGF-I/ALS Trial$40,350
R01 · FY2007 · NS · contact PI
IGF-I/ALS Trial$678,324
R01 · FY2006 · NS · contact PI
IGF-I/ALS Trial$32,400
R01 · FY2006 · NS · contact PI
IGF-I/ALS Trial$26,700
R01 · FY2006 · NS · contact PI
IGF-I/ALS Trial$1,436,847
R01 · FY2005 · NS
IGF-I/ALS Trial$1,942,892
R01 · FY2004 · NS
QUANTITATIVE FUNCTION IN MOTOR NEURON DISEASE$119,988
K23 · FY2004 · NS
IGF-I/ALS Trial$1,986,713
R01 · FY2003 · NS
QUANTITATIVE FUNCTION IN MOTOR NEURON DISEASE$119,988
K23 · FY2003 · NS
IGF-I/ALS Trial$1,547,356
R01 · FY2002 · NS
QUANTITATIVE FUNCTION IN MOTOR NEURON DISEASE$119,988
K23 · FY2002 · NS
QUANTITATIVE FUNCTION IN MOTOR NEURON DISEASE$119,988
K23 · FY2001 · NS
QUANTITATIVE FUNCTION IN MOTOR NEURON DISEASE$119,988
K23 · FY2000 · NS